Ivabradine Improves Left Ventricular Function During Chronic Hypertension in Conscious Pigs

No abstract is available for this paper.

• Publication year

  2015

• Venue

  HYPERTENSION

• Publication date

  2015-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/HYPERTENSIONAHA.114.04323PMID 25350985
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Heart rate and heart failure

  2016cited by this paper
• Heart rate reduction with ivabradine prevents thyroid hormone-induced cardiac remodeling in rat

  2013cited by this paper
• Heart rate reduction by If-inhibition improves vascular stiffness and left ventricular systolic and diastolic function in a mouse model of heart failure with preserved ejection fraction.

  2013cited by this paper
• Role of Heart Rate Reduction in the Prevention of Experimental Heart Failure: Comparison Between If-Channel Blockade and &bgr;-Receptor Blockade

  2012influential reference
• Impaired left ventricular function in the presence of preserved ejection in chronic hypertensive conscious pigs

  2012cited by this paper
• Heart Rate Reduction Induced by the If Current Inhibitor Ivabradine Improves Diastolic Function and Attenuates Cardiac Tissue Hypoxia

  2012cited by this paper
• Comparison of Effects of Ivabradine versus Carvedilol in Murine Model with the Coxsackievirus B3-Induced Viral Myocarditis

  2012cited by this paper
• Heart-rate reduction by If-channel inhibition with ivabradine restores collateral artery growth in hypercholesterolemic atherosclerosis.

  2012cited by this paper
• Heart rate and heart failure. Not a simple relationship.

  2011cited by this paper
• Heart Rate Reduction by Ivabradine Reduces Diastolic Dysfunction and Cardiac Fibrosis

  2011cited by this paper
• Chronic heart rate reduction with ivabradine improves systolic function of the reperfused heart through a dual mechanism involving a direct mechanical effect and a long-term increase in FKBP12/12.6 expression.

  2010cited by this paper
• Heart Rate Reduction for 12 Months With Ivabradine Reduces Left Ventricular Mass in Cardiac Allograft Recipients

  2009cited by this paper
• Heart Rate Reduction by Ivabradine Reduces Oxidative Stress, Improves Endothelial Function, and Prevents Atherosclerosis in Apolipoprotein E–Deficient Mice

  2008cited by this paper
• Improvement of regional myocardial blood flow and function and reduction of infarct size with ivabradine: protection beyond heart rate reduction.

  2008cited by this paper
• Pleiotropic action(s) of the bradycardic agent ivabradine: cardiovascular protection beyond heart rate reduction

  2008cited by this paper
• Direct evidence for calcium conductance of hyperpolarization-activated cyclic nucleotide-gated channels and human native If at physiological calcium concentrations.

  2008cited by this paper
• Heart rate in the pathophysiology of coronary blood flow and myocardial ischaemia: benefit from selective bradycardic agents

  2008cited by this paper
• Heart rate and microinflammation in men: a relevant atherothrombotic link

  2007cited by this paper
• Conversion of post-systolic wall thickening into ejectional thickening by selective heart rate reduction during myocardial stunning.

  2007cited by this paper
• Calcium influx through If channels in rat ventricular myocytes.

  2007cited by this paper
• The role of heart rate in the development of cardiovascular disease

  2007cited by this paper
• Heart rate reduction by inhibition of If or by β‐blockade has different effects on postsystolic wall thickening

  2007cited by this paper
• Cardiac dysfunction in heart failure: the cardiologist's love affair with time.

  2006cited by this paper
• Phenotypic adaptation of the late preconditioned heart: myocardial oxygen consumption is reduced.

  2006cited by this paper
• Paradoxical Cellular Ca2+ Signaling in Severe but Compensated Canine Left Ventricular Hypertrophy

  2005cited by this paper
• Effect of Graded Heart Rate Reduction with Ivabradine on Myocardial Oxygen Consumption and Diastolic Time in Exercising Dogs

  2004cited by this paper
• Heart rate reduction during exercise-induced myocardial ischaemia and stunning.

  2004cited by this paper
• Differential effects of heart rate reduction and beta-blockade on left ventricular relaxation during exercise.

  2002cited by this paper
• The properties of the pacemaker current I(F)in human ventricular myocytes are modulated by cardiac disease.

  2001cited by this paper
• Effects of heart rate reduction with ivabradine on exercise-induced myocardial ischemia and stunning.

  2001cited by this paper
• Attenuation of changes in sarcoplasmic reticular gene expression in cardiac hypertrophy by propranolol and verapamil

  2000cited by this paper
• Reduced subendocardial ryanodine receptors and consequent effects on cardiac function in conscious dogs with left ventricular hypertrophy.

  1999cited by this paper
• Effect of treadmill exercise on transmural distribution of blood flow in hypertrophied left ventricle.

  1998cited by this paper
• Effect of treadmill exercise on transmural distribution of blood flow in hypertrophied left ventricle.

  1998cited by this paper
• Coronary and hemodynamic effects of S 16257, a new bradycardic agent, in resting and exercising conscious dogs.

  1995cited by this paper
• Electrophysiological effects of S 16257, a novel sino‐atrial node modulator, on rabbit and guinea‐pig cardiac preparations: comparison with UL‐FS 49

  1994cited by this paper
• Mechanisms of subendocardial dysfunction in response to exercise in dogs with severe left ventricular hypertrophy.

  1992cited by this paper
• Reduced subendocardial coronary reserve. A potential mechanism for impaired diastolic function in the hypertrophied and failing heart.

  1990cited by this paper
• Exercise-induced subendocardial dysfunction in dogs with left ventricular hypertrophy.

  1990cited by this paper
• Effect of loading conditions, contractile state, and heart rate on early diastolic left ventricular filling in conscious dogs.

  1990cited by this paper
• Mechanisms of improved ischemic regional dysfunction by bradycardia. Studies on UL-FS 49 in swine.

  1989cited by this paper
• Elimination of exercise-induced regional myocardial dysfunction by a bradycardiac agent in dogs with chronic coronary stenosis.

  1987cited by this paper
• Relationship between systolic time intervals and arterial blood pressure

  1986cited by this paper
• Dynamics of cardiac output and systolic time intervals in supine and upright exercise.

  1983cited by this paper
• Myocardial relaxation. II. Hemodynamic determinants of rate of left ventricular isovolumic pressure decline.

  1980cited by this paper
• Cardiac responses to impulse exercise and recovery: systolic time intervals.

  1979cited by this paper
• Systolic time intervals during combined hand cooling and head-up tilt.

  1979cited by this paper
• Systolic time intervals during combined hand cooling and head-up tilt.

  1979cited by this paper
• A study of systolic time intervals during uninterrupted exercise.

  1978cited by this paper
• A study of systolic time intervals during uninterrupted exercise.

  1977cited by this paper

• Sexual Dimorphism in Animal Models of Heart Failure with Preserved Ejection Fraction.

  2025cites this paper
• Ivabradine restores tonic cardiovascular autonomic control and reduces tachycardia, hypertension and left ventricular inflammation in post-weaning protein malnourished rats.

  2024cites this paper
• Three-vessel coronary infusion of cardiosphere-derived cells for the treatment of heart failure with preserved ejection fraction in a pre-clinical pig model

  2023influential citation
• The effect of glucagon-like peptide-1 receptor agonist (GLP1RA) on hypertensive-induced heart failure with preserved ejection fraction and hypertensive cardiomyopathy

  2023cites this paper
• Concomitant systolic and diastolic alterations during chronic hypertension in pig.

  2019cites this paper
• Modulation of Sympathetic Activity and Innervation With Chronic Ivabradine and β-Blocker Therapies: Analysis of Hypertensive Rats With Heart Failure

  2019cites this paper
• Catheter-Based Splanchnic Denervation for Treatment of Hypertensive Cardiomyopathy.

  2019cites this paper
• Effect of Ivabradine on a Hypertensive Heart and the Renin-Angiotensin-Aldosterone System in L-NAME-Induced Hypertension

  2018cites this paper
• Ivabradine improves left ventricular twist and untwist during chronic hypertension.

  2018cites this paper
• Cardiac autonomic neuropathy: Risk factors, diagnosis and treatment

  2018cites this paper
• Caractérisation et modulation pharmacologique de la fonction ventriculaire gauche et du couplage contraction-relaxation par la mesure de la torsion et de la détorsion au cours de l’hypertension artérielle chronique

  2017cites this paper
• Improvement of left ventricular filling by ivabradine during chronic hypertension: involvement of contraction-relaxation coupling

  2016cites this paper
• Ivabradine in Management of Heart Failure: a Critical Appraisal

  2016cites this paper
• Ivabradine: Cardioprotection By and Beyond Heart Rate Reduction

  2016cites this paper
• Heart rate reduction in coronary artery disease and heart failure

  2016cites this paper
• Vascular endothelial dysfunction and pharmacological treatment.

  2015cites this paper
• Vascular Health and Risk Management Dovepress Advances in the Management of Heart Failure: the Role of Ivabradine

  year unknowncites this paper